Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions, ailments that require frequent drug administration for a protracted period of time.
Article / Apr 30, 2010
Inhalation: Going Beyond Asthma. Interview: Peter Villax and Jason Suggett
Drug Delivery Technology, April 2010